pharmacodynamic and clinical endpoint BE study [Design Issues]

posted by Jasmin – 2007-07-31 10:07 (6907 d 13:41 ago) – Posting: # 944
Views: 6,447

Dear Sir,

Thanks for solving my confusion. I understood the difference between Clinical end point study and pharmacodynamic study.

kindly solve one more query.

which condition any regulatory wants Clinical end point study?

is there any specific criteria or product category in Clinical end point study?

with best regards

Jasmin

Complete thread:

UA Flag
Activity
 Admin contact
23,655 posts in 4,993 threads, 1,570 registered users;
279 visitors (0 registered, 279 guests [including 20 identified bots]).
Forum time: 23:49 CEST (Europe/Vienna)

The real struggle is not between the right and the left
but between the party of the thoughtful
and the party of the jerks.    Jimmy Wales

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5